Research Solutions, Inc. (RSSS) operates as a vertical SaaS and AI provider that simplifies research workflows for academic institutions, life science firms, and other research organizations. Its fiscal first-quarter 2027 results, covering the period ended September 30, 2026, offer a clear window into the company's ongoing transition from lower-margin transaction revenue toward a more predictable, higher-margin platform model. In my view, the key question remains whether B2B subscription growth and AI adoption can scale fast enough to counterbalance softness in the transaction segment. With the stock still well below its 52-week highs, this report served as an important checkpoint on the company's ability to maintain profitability and cash generation while investing in products such as Article Galaxy and Scite.
Research Solutions reported total revenue of $11.9 million for the quarter, down 3.3% from $12.3 million a year earlier. Platform revenue increased 3.7% to $5.3 million, while transaction revenue declined 8.2% to $6.6 million on lower paid order volume. Total ARR rose 5.7% to $22.5 million, which included $16.5 million in B2B ARR (up 11.5%) and $6.0 million in B2C ARR (down 7.5%). AI-related ARR reached $1.1 million, up 38% sequentially.
Net income came in at $765,000, or $0.02 per diluted share, essentially unchanged from $749,000, or $0.02 per share, in the year-ago quarter. Adjusted net income was $1.2 million, or $0.04 per diluted share, beating the consensus estimate of roughly $0.03. Revenue, however, missed the $12.0 million to $12.2 million range analysts had projected.
Gross margin widened 300 basis points to 53.6%, supported by the platform mix shift and an improvement in transaction margins to 26.7% from 23.8%. Adjusted EBITDA totaled $1.0 million, down 30.3% from $1.5 million, as general and administrative expenses rose 32.8% due to legal and severance costs. Cash flow from operations increased to $1.2 million, and the company finished the quarter with $12.6 million in cash after paying $1.2 million toward its Scite earn-out. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares of Research Solutions closed at $1.89 on November 16, 2026, down roughly 6% following the report. The reaction reflected a mixed picture: investors appeared to appreciate the adjusted earnings beat and continued progress in B2B and AI-related ARR, yet the top-line shortfall and lower adjusted EBITDA highlighted ongoing pressure from the transaction business and higher operating costs. The stock is still down more than 30% over the past 12 months, pointing to cautious sentiment ahead of the release. The November 11 announcement of a $1 million enterprise Scite agreement with a Fortune 500 biopharmaceutical company, the largest such deal to date, stood out as a positive development that could influence near-term perceptions.
Looking ahead, the focus will be on whether the platform business can keep compounding while the transaction segment stabilizes. Management continues to emphasize the move toward a higher-margin, recurring revenue model, with platform revenue now representing 45% of the total, up from 42% a year earlier. The pace of B2B ARR growth, which eased from 14% in fiscal 2026 to 11.5% this quarter, will serve as a useful gauge of new sales and upsell efforts.
AI adoption remains a central theme. Recent integrations of Article Galaxy and Scite with ChatGPT, Claude, and Microsoft Copilot place the company's tools inside the AI-driven workflows researchers are adopting. The 38% sequential increase in AI-related ARR indicates traction, though investors will want to see this momentum convert into larger, sustained enterprise contracts.
Cost control also warrants attention. The rise in general and administrative expenses weighed on adjusted EBITDA this quarter, but if those items prove non-recurring, profitability could improve in coming periods. The company continues to work through its Scite earn-out, now reduced to $5.6 million, while maintaining a debt-free balance sheet and positive operating cash flow.
Finally, tracking transaction active customer counts and the trajectory of gross margins will be important. With transaction revenue still declining and B2C ARR under pressure, stabilizing the top line will depend on continued platform acceleration and disciplined cost management throughout the fiscal year. From what I see, these factors will determine how sustainable the recent progress really is.
I often turn to Tickeron’s AI Screener when evaluating companies like Research Solutions after earnings. It lets me quickly filter for comparable names in the software and AI sectors based on technical patterns, fundamentals, and performance metrics, which helps put the quarter’s results in broader context without spending hours on manual research.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RSSS saw its Momentum Indicator move above the 0 level on November 11, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 107 similar instances where the indicator turned positive. In 83 of the 107 cases, the stock moved higher in the following days. The odds of a move higher are at 78%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RSSS's RSI Oscillator exited the oversold zone, 18 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for RSSS just turned positive on November 11, 2026. Looking at past instances where RSSS's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.
Following a +1.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where RSSS advanced for three days, in 141 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 54 cases where RSSS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RSSS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
RSSS broke above its upper Bollinger Band on November 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RSSS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. RSSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.968) is normal, around the industry mean (-1.922). P/E Ratio (20.222) is within average values for comparable stocks, (9.599). Projected Growth (PEG Ratio) (1.381) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.383) is also within normal values, averaging (70.699).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RSSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the provision of information technology
Industry PackagedSoftware